InvestorsHub Logo
icon url

powerwalker

12/22/23 7:44 AM

#443665 RE: ExtremelyBullishZig #443632

Ziggy, Anavex has a large enough size in the P2b/2 trial. Remember Biocr*p had only 300 participants in its submission for its adu*crap drug after the exhaustive review for any benefits. I think it had over 3,000 people in the trial.
Bullish
Bullish